Four technologies share $200,000 in grants addressing youth substance misuse, addiction
Summary
Developing a remote therapeutic monitoring platform designed to address the critical challenges associated with stimulant medication treatment for adolescents with attention-deficit/hyperactivity disorder, a group at greater risk for substance abuse. Based on collected patient data, Levls proprietary, early risk detection mechanism is designed to enhance the safety and effectiveness of stimulant medication treatments in response to the rise in misuse and diversion among youth.Sibel Health, Chicago, Ill. Developer of an evidence-based digital therapeutic platform that aims to increase access to care, reduce wait times, provide caregiver tools and offer personalized mental health support. APDI aims to provide early support to promising innovations, recognizing that additional funding may be available from NIDA in the future.APDI is one of five nonprofit consortia in the FDAs Pediatric Device Consortia grant program that receives funding to provide a platform of services, expertise and grants to support pediatric innovators in bringing medical devices to the market that specifically address the unmet needs of children. This pediatric academic health system offers expert care through a convenient, community-based network and locations in the D.C. metropolitan area, including Maryland and Virginia.